Biotechnology company focused on developing advanced mRNA technologies
RIBOPRO has raised €1.9M across 1 funding round from 4 investors, most recently a Debt round in Jan 2024. Based in Noord-Brabant, Netherlands; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-01-12 | Debt | €1.9M |
| BOM,the Fredriks family,Vlasroot,Wietse Mulder |
| View deal → |
